Vital Signs: Deaths Among Persons with Diagnosed HIV Infection, United States, 2010-2018
- PMID: 33211683
- PMCID: PMC7676640
- DOI: 10.15585/mmwr.mm6946a1
Vital Signs: Deaths Among Persons with Diagnosed HIV Infection, United States, 2010-2018
Abstract
Background: Life expectancy for persons with human immunodeficiency virus (HIV) infection who receive recommended treatment can approach that of the general population, yet HIV remains among the 10 leading causes of death among certain populations. Using surveillance data, CDC assessed progress toward reducing deaths among persons with diagnosed HIV (PWDH).
Methods: CDC analyzed National HIV Surveillance System data for persons aged ≥13 years to determine age-adjusted death rates per 1,000 PWDH during 2010-2018. Using the International Classification of Diseases, Tenth Revision, deaths with a nonmissing underlying cause were classified as HIV-related or non-HIV-related. Temporal changes in total deaths during 2010-2018 and deaths by cause during 2010-2017 (2018 excluded because of delays in reporting), by demographic characteristics, transmission category, and U.S. Census region of residence at time of death were calculated.
Results: During 2010-2018, rates of death decreased by 36.6% overall (from 19.4 to 12.3 per 1,000 PWDH). During 2010-2017, HIV-related death rates decreased 48.4% (from 9.1 to 4.7), whereas non-HIV-related death rates decreased 8.6% (from 9.3 to 8.5). Rates of HIV-related deaths during 2017 were highest by race/ethnicity among persons of multiple races (7.0) and Black/African American persons (5.6), followed by White persons (3.9) and Hispanic/Latino persons (3.9). The HIV-related death rate was highest in the South (6.0) and lowest in the Northeast (3.2).
Conclusion: Early diagnosis, prompt treatment, and maintaining access to high-quality care and treatment have been successful in reducing HIV-related deaths and remain necessary for continuing reductions in HIV-related deaths.
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Figures
References
-
- Samji H, Cescon A, Hogg RS, et al. ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013;8:e81355. 10.1371/journal.pone.0081355 - DOI - PMC - PubMed
-
- Marcus JL, Leyden W, Anderson AN, et al. Increased overall life expectancy but not comorbidity-free years for people with HIV [abstract 151]. Presented at the 2020 Conference on Retroviruses and Opportunistic Infections; March 8–11, 2020; Boston, Massachusetts. https://www.croiconference.org/abstract/increased-overall-life-expectanc...
-
- Heron M. Deaths: leading causes for 2017. National Vital Statistics report vol. 68, no. 6. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_06-508.pdf - PubMed
-
- CDC. Diagnoses of HIV infection in the United States and dependent areas, 2018. HIV surveillance report 2018 (updated), vol. 31. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-31/index.html
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
